LncRNA Information | ||||||
---|---|---|---|---|---|---|
ID | EL0530 | Name | GATA3-AS1 | Aliases | N/A | |
Species | Homo sapiens | Chromosome | 10 | Start site | 8050450 | |
End site | 8053484 | Chain | minus | Exon NO. | 2 | |
Assembly | Ensembl Release 89 | Class | lincRNA | NCBI accession | NR_024256, NR_104328, NR_104330, NR_104329, NR_104327, NR_104336 | |
Ensembl | ENSG00000197308 | Sequence |
Disease | |||||||||
---|---|---|---|---|---|---|---|---|---|
Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
renal cell carcinoma | microarray, qPCR etc. | RCC tissue | down-regulated | N/A | From five paired samples we identified hundreds of significantly differentiated lncRNAs. Specifically, the most upregulated lncRNAs were: uc001vjj.1, ENST00000414223, BC047917, uc003erl.1, and uc009wkz.1, of which uc001vjj.1 was the highest. The most highly downregulated were: ENST00000507950, uc001aka.2, NR_026860, NR_024256, and BC070168, of which ENST00000507950 showed the largest downregulation. | 24905231 | Lnc2Cancer | ||
Function (not disease relevant) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Methods | Sample/condition | Expression pattern | Dysfunction type | Description | PMID | Source | |||
N/A | CD4+ T-cell | N/A | N/A | N/A | 23870669 | ||||